Dentistry , the use of hydroxyapatite, or its synthetically manufactured form, nano-hydroxyapatite, is not yet common practice. Some studies suggest it is useful in counteracting
dentine hypersensitivity, preventing sensitivity after teeth bleaching procedures and cavity prevention. Avian eggshell hydroxyapatite can be a viable filler material in bone regeneration procedures in oral surgery.
Dentine sensitivity Nano-hydroxyapatite possesses bioactive components which can prompt the mineralisation process of teeth, remedying hypersensitivity. Hypersensitivity of teeth is thought to be regulated by fluid within dentinal tubules. Hydroxylapatite has shown significant medium and long-term desensitizing effects on dentine hypersensitivity using evaporative stimuli and the visual analogue scale (alongside potassium nitrate, arginine, glutaraldehyde with hydroxyethyl methacrylate, hydroxyapatite, adhesive systems, glass ionomer cements and laser).
Co-agent for bleaching Teeth bleaching agents release reactive oxygen species which can degrade enamel. In addition to remineralisation, in vitro studies have shown that toothpastes containing nano-hydroxyapatite have the potential to reduce
biofilm formation on both tooth enamel and
resin-based composite surfaces.
As a dental material Hydroxyapatite is widely used within dentistry and
oral and maxillofacial surgery, due to its chemical similarity to hard tissue. In the future, there are possibilities for using nano-hydroxyapatite for tissue engineering and repair. The main and most advantageous feature of nano-hydroxyapatite is its biocompatibility. It is chemically similar to naturally occurring hydroxyapatite and can mimic the structure and biological function of the structures found in the resident extracellular matrix. Therefore, it can be used as a scaffold for engineering tissues such as bone and cementum. The
European Commission's
Scientific Committee on Consumer Safety (SCCS) reissued an updated opinion in 2023, where it cleared rod-shaped nano hydroxyapatite of concerns regarding genotoxicity, allowing consumer products to contain concentrations of nano hydroxyapatite as high as 10% for toothpastes and 0.465% for mouthwashes. However, it warns of needle-shaped nano hydroxyapatite and of inhalation in spray products. It stated: In July 2025, the Scientific Committee on Consumer Safety (SCCS) adopted its fourth opinion (Submission IV), concluding that nano‑hydroxyapatite is safe at concentrations up to 29.5 % in toothpaste and up to 10 % in mouthwash, under defined particle morphology constraints.
Dermal filler In 2006, the US
Food and Drug Administration approved an injectable
dermal filler form of calcium hydroxyapatite (Radiesse) for the correction of moderate-to-severe facial folds, such as nasolabial folds, and for the restoration of volume in cases of
HIV-associated facial lipoatrophy. The formulation typically consists of synthetic, smooth calcium hydroxyapatite microspheres (20–45 μm in diameter) suspended in a
carboxymethylcellulose carrier gel. Upon injection in the skin, the gel provides immediate mechanical volumization, while the microspheres function as a scaffold for the endogenous production of
collagen,
elastin, and
proteoglycans. This process is reported to lead to increases in skin thickness and structural elasticity. Clinical applications include jawline augmentation, hand rejuvenation, and the treatment of midface volume loss. Calcium hydroxyapatite is biodegradable, with the microspheres eventually undergoing macrophage-mediated
phagocytosis and metabolic clearance over a period of approximately 12 to 30 months. ==Chromatography==